10x Genomics Patents – Key Insights and Stats

10x Genomics has a total of 705 patents globally, out of which 162 have been granted. Of these 705 patents, more than 75% patents are active. United States of America is where 10x Genomics has filed the maximum number of patents, followed by China and Europe. Parallelly, United States of America seems to be the main focused R&D center and is also the origin country of 10x Genomics.

10x Genomics was founded in the year 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness. Company is doing business in designing and manufacturing gene sequencing technology used in scientific research. As of December 2021, 10x Genomics has a market cap of $16.35 Billion.

Do read about some of the most popular patents of 10x Genomics which have been covered by us in this article and also you can find 10x Genomics’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over 10x Genomics’s patent portfolio.

How many patents does 10x Genomics have?

10x Genomics has a total of 705 patents globally. These patents belong to 187 unique patent families. Out of 705 patents, 532 patents are active.

How many 10x Genomics patents are Alive/Dead?

Worldwide Patents

10x Genomics Worldwide Legal Trends

Patent Families

10x Genomics Patent Portfolio

How Many Patents did 10x Genomics File Every Year?

10x Genomics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or Grant10x Genomics Applications Filed10x Genomics Patents Granted
201211
2013171
2014351
2015721
2016835
2017597
201810121
201913342
202012348
20217935

How Many Patents did 10x Genomics File in Different Countries?

10x Genomics Worldwide Filing in Top 10 countries

Countries in which 10x Genomics Filed Patents

CountryPatents
United States Of America314
China59
Europe42
Singapore39
Australia21
Korea (South)16
Canada16
Israel13
India13
Mexico12
Brazil10
Japan6
Germany5
United Kingdom2
Denmark2

Where are Research Centers of 10x Genomics Patents Located?

10x Genomics R&D Centers

10 Best 10x Genomics Patents

US20140378345A1 is the most popular patent in the 10x Genomics portfolio. It has received 337 citations so far from companies like Nugen Technologies, Cellular Research and Prognosys Biosciences.

Below is the list of 10 most cited patents of 10x Genomics:

Publication NumberCitation Count
US20140378345A1337
US20140155295A1334
US20150376609A1309
US20140378349A1196
US20150005200A1175
US20140235506A1167
US8298767B2166
US20150005199A1157
US20140378322A1157
US8679756B1154

Count of 102 and 103 Type Rejections based on 10x Genomics Patents

10x Genomics Patent Portfolio

Top 10x Genomics Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US20140378349A17
US9644204B26
US20150376609A15
US9388465B25
US10357771B24
US20140155295A14
US20150005200A14
US20150376700A13
US8298767B22
US20140235506A12

What Percentage of 10x Genomics US Patent Applications were Granted?

10x Genomics (Excluding its subsidiaries) has filed 217 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 112 have been granted leading to a grant rate of 73.2%.

Below are the key stats of 10x Genomics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for 10x Genomics?

Law FirmTotal ApplicationSuccess Rate
10X Wsgr10971.08%
Morgan Lewis & Bockius Llp 10X Genomics5178.79%
Clark Elbing Llp 10X Genomics Inc3090.00%
Fisherbroyles Llp 10X Genomics766.67%
10Xgenomics 59903450.00%
Fish & Richardson P C40%
10X Genomics Inc10.00%
10X Genomics Inc C O Morrison & Foerster Llp10%
Mintz Levin 10X Genomics10.00%
Morgan Lewis & Bockius Llp Sf10.00%

As new technologies and innovative methodologies assist and speed traditional procedures, immunology research is changing and adapting. Researchers are increasingly turning to multiomic single cell and spatial characterization technology to delve deeper into the complex molecular and cellular networks and responses of the immune system, and to translate discoveries into actionable insights for the treatment of infectious diseases, autoimmune disorders, and cancer.

10x Genomics is continuing to explore novel uses for these technologies and advance discovery in key areas of immunology research, such as:

  • Vaccines and Antibody Discovery: Scientists created an unbiased, high-throughput method for screening the antibody repertoire of single B cells in order to speed up antibody discovery.
  • Infectious Illness: Scientists identified epithelial–immune cellular interaction, which could lead to macrophages and neutrophils being drawn to infection-prone areas.
  • Immunology’s Cellular and Molecular Mechanisms: Scientists discovered two distinct stages of innate lymphoid cell formation, as well as the molecular mechanisms that control cell fate determination.
  • Immuno-oncology: Researchers discovered that immune checkpoint blockade therapy led to the recruitment of enlarged CD8+T cell clones from beyond the tumour microenvironment.

EXCLUSIVE INSIGHTS COMING SOON!

What are 10x Genomics key innovation segments?

What Technologies are Covered by 10x Genomics?

The chart below distributes patents filed by 10x Genomics in different countries on the basis of the technology protected in patents. It also represents the markets where 10x Genomics thinks it’s important to protect particular technology inventions.

R&D Focus: How 10x Genomics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by 10x Genomics?

Table of Content

Insights you may find interesting

Related Articles

Medinol Patents – Insights & Stats (Updated 2023)

Medinol has a total of 919 patents globally, out of which 1568 have been granted. Of these 919 patents, more than 16% patents are active. United States of America is where Medinol has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, United States of America

Read More »

Creo Medical Patents – Insights & Stats (Updated 2023)

Creo Medical has a total of 2132 patents globally, out of which 813 have been granted. Of these 2132 patents, more than 85% patents are active. United Kingdom is where Creo Medical has filed the maximum number of patents, followed by Europe (EPO) and China. Parallelly, United Kingdom seems to

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.